BrainCells

Biotechnology startup focused on drugs intended to stimulate the growth of new neurons.

Launch date

2003

Employees

Market cap

Enterprise valuation

San Diego California (HQ)

Date	Investors	Amount	Round
Jul 2005	Pappas Capital Bay City Capital NeuroVentures Oxford Bioscience Partners	$17.7m	Series A
Mar 2008	Pappas Capital Bay City Capital NeuroVentures MedImmune Ventures Technology Partners Oxford Bioscience Partners	$30.0m	Series B
Apr 2008	New Enterprise Associates Alexandria Equities	$20.0m	Series B
Aug 2011	N/A	$995k	Debt
Aug 2011	N/A	$4.0m	Early VC
Jan 2012	N/A	$2.0m	Debt
Total Funding		$71.7m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about BrainCells